Bill · H.R. 4392· House(119-HR-4392)

Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025

Age: 51 years

Ohio

Introduced: 7/15/2025
Last activity: 7/15/2025 — Referred to the House Committee on Energy and Commerce.
Sponsored by: Shontel Brown
Cosponsors: - 54 - 0

Health

Introduced
In Committee

What this bill would do

This bill, titled the "Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025," authorizes the Secretary of Health and Human Services to award grants to increase early detection of and intervention for uterine fibroids. The Secretary is tasked with conducting or supporting research to create evidence-based strategies for early detection in healthcare settings. Grants may also be awarded to States to implement programs and public awareness campaigns. These State programs can fund activities such as screening procedures, patient navigation, and improving access to healthcare. Additionally, the Secretary may award grants for specific research, including studies on pain management disparities and other intrauterine conditions. Finally, the Act requires regular reports to be submitted to Congress regarding grant results and research developments.

Yes· 3 of 8

Would women be better off under this?+8
The bill directly addresses gynecological health issues that specifically affect women.
Does this put more money into medical research?+6
The act authorizes research into uterine fibroids, pain management disparities, and related intrauterine conditions.
Does this make health care easier to get in general?+5
The bill enhances healthcare access through grants for screening, patient navigation, and increased awareness of uterine fibroids.